Rathbones Group PLC Increases Stock Position in GE HealthCare Technologies Inc. $GEHC

Rathbones Group PLC raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 20.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 370,099 shares of the company’s stock after acquiring an additional 63,669 shares during the period. Rathbones Group PLC owned approximately 0.08% of GE HealthCare Technologies worth $27,794,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. True North Advisors LLC boosted its position in shares of GE HealthCare Technologies by 2.0% during the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares during the period. Klingman & Associates LLC increased its holdings in GE HealthCare Technologies by 4.0% in the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after purchasing an additional 139 shares during the last quarter. Colonial Trust Advisors raised its position in GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after purchasing an additional 139 shares during the period. Golden State Wealth Management LLC lifted its stake in GE HealthCare Technologies by 7.4% during the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after purchasing an additional 148 shares in the last quarter. Finally, Exchange Traded Concepts LLC lifted its stake in GE HealthCare Technologies by 1.3% during the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock worth $863,000 after purchasing an additional 150 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research reports. Barclays lifted their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Bank of America raised their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Citigroup lifted their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Finally, Piper Sandler boosted their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Price Performance

GEHC stock opened at $74.27 on Friday. The stock has a market cap of $33.85 billion, a price-to-earnings ratio of 16.29, a PEG ratio of 1.63 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The business has a 50 day moving average price of $81.81 and a 200 day moving average price of $78.57.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.